Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced that the ...
The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes. The Food and Drug Administration (FDA) has ...
This morning Abbott revealed that its much anticipated integrated continuous glucose monitoring system the FreeStyle Libre 2 is now FDA cleared for adults and kids over the age of 4 with diabetes. The ...
SAN FRANCISCO--(BUSINESS WIRE)--Ambrosia announced the availability of LinkBluCon App on Fitbit platform. Now Ambrosia's NightRider BluCon and LinkBluCon app users can use Fitbit Ionic, Versa and ...